Press release
Patient Engagement Solutions Market to Reach $96.7 Billion by 2035, Growing at 18.1% CAGR | athenahealth, Wolters Kluwer, Veradigm
The global patient engagement solutions market, valued at USD 18.0 billion in 2025, will climb to USD 21.6 billion in 2026 and is forecast to reach USD 96.7 billion by 2035, compounding at a 18.1% CAGR across the 2026 to 2035 period, according to new research published by Roots Analysis. The numbers reflect intensifying demand for digital health infrastructure that closes the gap between patients and providers, as healthcare systems worldwide push accountability and care coordination further toward the individual.To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/patient-engagement-solutions-market/request-sample.html
Market Overview
Patient engagement solutions are digital platforms, software tools, and integrated services that enable patients to access their medical records, schedule appointments, communicate with clinicians, manage chronic conditions remotely, and stay informed about their own care. The category spans patient portals, mobile applications, remote monitoring tools, AI-powered chatbots, EHR integration modules, and patient education systems. What ties them together is a shared goal: transforming the patient from a passive recipient of care into an active participant in health decisions.
The clinical rationale is well established. Studies cited in the Roots Analysis report show that engaged patients are three times less likely to report unmet medical needs and twice as likely to seek timely care compared with those who remain passive. For health systems facing rising readmission penalties and population health mandates, that data translates directly into financial performance. The COVID-19 pandemic accelerated the adoption curve sharply, normalizing telehealth, virtual chronic disease management, and remote patient monitoring at a pace regulators and providers had not anticipated.
Private capital is following clinical validation. Since 2018, investors have collectively deployed more than USD 5.7 billion into the sector. In October 2025, Assort Health secured USD 76 million in Series B funding led by Lightspeed Venture Partners to advance its agentic AI engagement platform. In March 2024, Providence spun out Praia Health, which raised USD 20 million to build an AI system that personalizes the digital healthcare experience by unifying patient data across provider websites, apps, and services.
Key Growth Drivers
Rising Chronic Disease Burden Demands Continuous Patient Connectivity. More than 420 million people worldwide are living with diabetes, and cardiovascular diseases account for approximately 18 million deaths annually. Conditions of this scale require ongoing monitoring, medication adherence support, and frequent patient-provider touchpoints that in-person visits alone cannot sustain.
AI Integration Is Raising the Ceiling on What Platforms Can Deliver. Research from the University of Maryland School of Medicine found that ChatGPT achieves roughly 88% accuracy in answering patient queries. In March 2024, Doceree launched Spark at HIMSS, an AI-powered platform embedding personalized clinical messaging directly into EHR workflows for over 700,000 providers across more than 50 platforms.
Clinical Trial Recruitment Pressures Are Expanding the Commercial Use Case. Patient recruitment now takes more than 18 months on average in multi-site clinical trials. Pharmaceutical companies are turning to patient engagement software to accelerate enrollment, improve retention, and shift portions of trial participation to decentralized models.
Cloud Deployment and EHR Integration Lower the Adoption Barrier. More than 75% of solution providers offer cloud-based deployment options. CipherHealth's January 2023 partnership with SADA to integrate socioeconomic data into its platform via Google Cloud illustrates how cloud-native solutions are adding data depth alongside convenience.
Regulatory Evolution Is Creating Compliance-Driven Demand. Shifting standards around interoperability, patient data access, and value-based care contracting are pushing healthcare organizations to upgrade their engagement infrastructure. Compliance is becoming a purchase driver in its own right.
Market Segmentation and Dominant Categories
The patient engagement solutions market segments across deployment option, solution type, application area, and end user. Cloud-based solutions lead the deployment category, with more than 75% of providers offering them as their primary model. Home health management holds the largest application area share at 45% of the overall market, a position expected to hold through 2035 as remote monitoring scales. The five solution categories include appointment management, EHR integration, patient education, remote patient monitoring, and a residual group covering billing and medication adherence tools. The research and development sub-segment, driven by clinical trial engagement, represents the fastest-evolving category in terms of solution sophistication.
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/patient-engagement-solutions-market/request-quote.html
Regional Insights
North America holds approximately 31% of the global market, with North America and Europe together accounting for roughly 65% of total share. The United States drives North American leadership through mature EHR infrastructure, active venture capital deployment, and regulatory frameworks that link reimbursement to care coordination quality. Asia is the fastest-growing region through 2035, supported by expanding healthcare infrastructure in India and China, rising smartphone penetration, and government digital health investment, combined with a large chronic disease population and a low base of installed engagement technology.
Competitive Landscape
The market includes approximately 420 companies. Key players profiled include athenahealth, Coviu, GetWellNetwork, Health Catalyst, MediBuddy, Mocero Health, Orion Health, Physitrack, SolvEdge, Veradigm, Well-Beat, and Wolters Kluwer. The competitive dynamic blends consolidation among established vendors with fast-moving AI-native challengers. Elsevier's March 2026 acquisition of Mytonomy, Rimidi's Care Network launch, and athenahealth's partnership expansions all signal that the main battleground is now EHR-integrated workflow ownership and AI-driven personalization, not just feature parity.
Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/patient-engagement-solutions-market.html
Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Patient Engagement Solutions Market to Reach $96.7 Billion by 2035, Growing at 18.1% CAGR | athenahealth, Wolters Kluwer, Veradigm here
News-ID: 4511839 • Views: …
More Releases from Roots Analysis
Nutrigenomics Market to Reach $3.07 Billion by 2035 at 12.8% CAGR | 3X4 Genetics …
The global nutrigenomics market, valued at USD 0.92 billion in 2025, will reach USD 1.04 billion in 2026 and is forecast to hit USD 3.07 billion by 2035, advancing at a compounded annual growth rate of 12.8% over the 2026-2035 period. The market's expansion reflects accelerating commercial and scientific interest in understanding how individual genetic profiles interact with diet, opening a direct pathway to precision nutrition and preventive healthcare at…
Metabolomics Market to Reach $1.06 Billion by 2035 at 14.8% CAGR | Metabolon, Cr …
The global metabolomics market, valued at USD 265 million in 2025 and USD 305 million in 2026, will grow to USD 1,059 million by 2035, compounding at 14.8% annually across the 2026-2035 forecast period. That trajectory reflects surging demand from pharmaceutical companies, academic research institutions, and contract research organizations that need precise metabolite profiling but lack the infrastructure to perform it in-house. The numbers make a clear business case: this…
Manufacturing Execution System Market to Reach $20.46 Billion by 2035 at 16.0% C …
The global manufacturing execution system market, valued at USD 4.62 billion in 2025, is projected to reach USD 5.36 billion in 2026 and USD 20.46 billion by 2035, representing a compound annual growth rate of 16.0% over the forecast period. Sustained demand from pharmaceutical, life science, and medical device manufacturers, combined with accelerating Industry 4.0 adoption, is pushing the market into one of its highest growth cycles on record.
To explore…
Bispecific Antibodies Market to Reach $16.81 Billion by 2035, Growing at 7.5% CA …
The global bispecific antibodies market, valued at USD 8.93 billion in 2025, will reach USD 16.81 billion by 2035, advancing at a compound annual growth rate of 7.5% over the forecast period from 2026 to 2035. Fifteen bispecific antibodies have already received regulatory approval worldwide, and a clinical pipeline of more than 220 candidates signals that the market's growth arc is far from exhausted. For biopharmaceutical executives, investors, and payers…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
